How Does the COVID-19 Antiviral Medications Workflow Compare to the Traditional Antiviral Production Pipeline


As the COVID-19 pandemic continues to progress researchers and scientists are starting to learn more about the virus in order to effectively combat it. One of those lessons is how the COVID-19 virus compares to other viruses when it comes to developing treatments. Justin Honore talked to Dr. Kishor Wasan, PH.D.,FAAPS, FCAHS, FCSPS, Chief Medical & Scientific Officer at Skymount Medical and a Distinguished University Scholar Adjunct Professor at the University of British Columbia about how COVID-19 vaccine research and production compare to the traditional antiviral and antibiotic production pipeline.

Follow us on social media for the latest updates in B2B!


Joy, Inc.: How We Built a Workplace People Love – Part 2
October 22, 2021
Here to give insights on this episode of CalTV by Calvary Robotics, Host Joe Gemma talked with Rich Sheridan, CEO and Chief Storyteller at Menlo Innovations; Speaker, Author of Chief Joy Officer and Joy, Inc.: Read more
Trends and Technology at InfoComm 2021
Don’t Touch This: Trends and Technology at InfoComm 2021
October 22, 2021
  Key Points: The cost in the LED market has dramatically decreased from a manufacturing perspective and a consumer demand perspective, LED's are a lot more attainable. The LED market is expected Read more
Mainstream Modular: The Engineering Specifics of Modular Construction
October 22, 2021
  DCI Engineers, a structural and civil engineering services company based out of Seattle, Washington, since 1988 partnered with Guerdon on several modular construction projects. Troy Bean, Read more